Repaglinide .5 mg/1

Repaglinide .5 mg tablets are an oral medication used to manage blood sugar levels in adults with type 2 diabetes. This fast-acting drug helps control glucose by stimulating insulin release from the pancreas.

Repaglinide .5 mg tablets are primarily used to manage blood sugar levels in adults with type 2 diabetes. This medication works by stimulating the pancreas to release insulin in response to meals, helping to control glucose levels. It is often prescribed as part of a broader treatment plan that includes diet and exercise. Repaglinide is particularly useful for those who need rapid blood sugar control before meals.

Common effects of Repaglinide .5 mg tablets may include mild to moderate hypoglycemia, particularly if meals are skipped or delayed. Some users may experience gastrointestinal discomfort, such as nausea or diarrhea. Headaches and dizziness are also reported in some cases. These effects vary among individuals and are not experienced by everyone.

Repaglinide .5 mg tablets should be handled with care, especially by individuals with a history of liver or kidney issues. It is important to follow the prescribed dosage and timing to avoid hypoglycemia. Regular monitoring of blood sugar levels is recommended. Consult a healthcare provider before starting or adjusting the medication.

Repaglinide .5 mg tablets may interact with certain medications, including other diabetes drugs, antibiotics, and antifungal agents. Alcohol consumption should be avoided as it can increase the risk of hypoglycemia. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.